Location
United States, North America
Cheque size
$100K - $5M
Investment Stage
Seed
Series A
Focus Areas
Health IT
Digital Health
BioTech
Pharmaceuticals
Medical Devices
About Investor
Mara Aspinall is Co-Founder and Managing Director at BlueStone Venture Partners (based in Tucson). She focuses on life sciences and healthcare technologies such as diagnostics, biotech, pharmaceuticals, medical devices, digital health, and health IT, typically at Seed and Series A. Her stated investment range is $100K – $5.0M. Her operating background includes senior leadership in diagnostics and genomics, including President/CEO of Ventana Medical Systems and leadership roles at Genzyme.
Previous investments
Predicta Biosciences
5M |2024
Paradigm Diagnostics
15M |2019
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,PS
Paul Straub
United States, North America
$100K - $2M
Pre Seed
,Seed
,SA
Shaun Abrahamson
United States, North America
$250K - $1M
Pre Seed
,Seed
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,SB
Steve Brownlie
United States, North America
$250K - $1.4M
Pre Seed
,Seed
,DG
Danielle Graham
Canada, North America
$100K - $300K
Pre Seed
,Seed
,Is this Your Profile?
If you have any updates, please fill out our form.